Chong Kun Dang Pharmaceutical financials at a glance

+ Portfolio

The revenue of Chong Kun Dang Pharmaceutical is reported as 1633.1125 billion Won in the fiscal year 2023. The earnings were 15391.24 Won per share in 2023, which was 127.3 higher than 2022. And about 155.76968 billion Won are reported as free cash flow in the financials of Chong Kun Dang Pharmaceutical 2023. Dividends of 925.06 Won per share were paid to shareholders of Chong Kun Dang Pharmaceutical stock KOSE:A185750 in fiscal 2023.

₩1.63T

Revenue

₩15.39k

Earnings Per Share

39.67%

Gross Margin %

₩172.52B

Free Cash Flow

Revenue

1,633,112.50

Earnings Per Share

15,391.24

Gross Margin %

39.67

Free Cash Flow

172,520.00

Financials

Year	Year	TTM	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014
Rev.	Revenue	N/A	₩1.63T	₩1.47T	₩1.33T	₩1.30T	₩1.08T	₩955.71B	₩884.28B	₩831.99B	₩592.49B	₩544.13B
GM %	Gross Margin %	36.63%	39.67%	36.46%	36.90%	37.54%	37.46%	39.78%	40.67%	40.25%	0.00%	0.00%
OM	Operating Margin	9.66%	14.77%	7.38%	7.05%	9.51%	6.91%	7.92%	8.79%	7.36%	0.00%	0.00%
EPS	Earnings Per Share	₩11.18k	₩15.39k	₩6.77k	₩3.17k	₩7.08k	₩4.30k	₩3.39k	₩4.26k	₩3.09k	₩-,511.69	₩2.66k
Div.	Dividends	N/A	₩925.06	₩952.38	₩907.03	₩822.70	₩740.43	₩705.17	₩671.59	₩639.61	₩426.41	₩568.55
PR %	Payout Ratio %	0	6.01%	14.06%	28.63%	11.62%	17.22%	20.78%	15.78%	20.67%	-83.33%	21.40%
Sha.	Shares	N/AM	12.73M	12.8M	12.39M	12.51M	12.53M	12.53M	12.6M	12.6M	11.44M	11.44M
OCF	Operating Cash Flow	N/A	₩196.99B	₩63.96B	₩15.28B	₩107.02B	₩80.84B	₩45.23B	₩80.23B	₩57.79B	₩7.27B	₩64.59B
FCF	Free Cash Flow	N/A	₩172.52B	₩19.34B	₩-32,941.72M	₩74.60B	₩60.72B	₩27.46B	₩68.83B	₩19.86B	₩-24,961.99M	₩45.85B
FCFS	Free Cash Flow Per Share	₩11.08k	₩19.60k	₩1.20k	₩-3,286.01	₩5.66k	₩4.84k	₩1.58k	₩5.57k	₩1.71k	₩0.00	₩0.00

Chong Kun Dang Pharmaceutical financials at a glance

Financials

Discover